Tata Capital Healthcare Fund invests in Atulaya Healthcare.
Chandigarh: Tata Capital Healthcare Fund (TCHF), a Healthcare and Pharma focused Private Equity Fund managed by Tata Capital Limited has committed to invest ~USD 10 million in Atulaya Healthcare.
Atulaya Healthcare is one of the leading integrated imaging and pathology services provider companies in North India. Atulaya provides diagnostic services including imaging, pathology, microbiology and specialized genetic tests across Punjab, Haryana, Himachal Pradesh, Uttarakhand and Jammu & Kashmir.
Atulaya also operates an FDG manufacturing cyclotron unit in Derabassi.
Atulaya Healthcare presently has a state of the art automated Central Reference Lab in Mohali which can process 20000 samples per day and an additional 7 integrated diagnostic centres.
70-80 collection points and above 500 b2b clients across the region and an army of qualified phlebotomists to cater to the customers not only at the centres but also by offering at-home collection services for pathology.
Mr. Pankaj Kansal, Director, Atulaya Healthcare said, “We at Atulaya healthcare are really delighted with this development and looking forward to leveraging the partnership with a healthcare-focused fund to grow the business organically by opening new locations and also by pursuing select inorganic opportunities.
The key objective of the fundraising is to expand presence, professionalize the management and scale the business to make Atulaya a leading brand in the integrated diagnostics space.
Mr. Anuj Gupta, Director, Atulaya Healthcare said, “North India’s is a key market and expansion of organized services delivery platforms is very much a crying need. Many new collection centres are to be opened in this region very soon.
We are the market leaders in the Upper North area and we are looking forward to leading as the biggest integrated diagnostic services in the Upper North West region of India.